Firm | Analyst |
---|---|
H.C. Wainwright | Edward White |
Maxim Group | Jason McCarthy |
ThinkEquity | Ashok Kumar |
Inhibikase Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Inhibikase Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Inhibikase Therapeutics, Inc. or its management. Inhibikase Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.